Growth Metrics

MeiraGTx Holdings (MGTX) EBIT Margin (2019 - 2025)

MeiraGTx Holdings posted quarterly EBIT Margin of 35.13% for Q4 2025, up 18234.0% year-on-year from N/an in Q4 2024, and up 100.31% on a QoQ basis from 11231.95% in Q3 2025.

MeiraGTx Holdings (MGTX) has 7 years of EBIT Margin data on file, last reported at 35.13% in Q4 2025.

  • For the quarter ending Q4 2025, EBIT Margin rose 18234.0% year-over-year to 35.13%; the trailing twelve-month figure through Dec 2025 stood at 105.07% (up 38837.0% YoY), and the FY2025 full-year result was 130.2%, up 36324.0% from the prior year.
  • EBIT Margin for Q4 2025 stood at 35.13%, up from 11231.95% in the prior quarter.
  • Across five years, EBIT Margin topped out at 776.38% in Q4 2022 and bottomed at 16279.79% in Q2 2024.
  • The 5-year median for EBIT Margin is 479.48% (2021), against an average of 2217.71%.
  • The widest annual swing landed in 2024, when EBIT Margin slumped 1546665 bps; it then jumped 1506621 bps in 2025.
  • A 5-year view of EBIT Margin shows it stood at 36.54% in 2021, then surged by 2224 bps to 776.38% in 2022, then slumped by 376 bps to 2144.8% in 2023, then soared by 93 bps to 147.22% in 2024, then jumped by 124 bps to 35.13% in 2025.
  • The last three EBIT Margin figures came in at 35.13% (Q4 2025), 11231.95% (Q3 2025), and 1213.57% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -6.43%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 38.10%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 17.83%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 23.02%
10 MeiraGTx Holdings 856.58 Mn 790.65 Mn 74.89 Mn 35.13%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 35.13%
Sep 30, 2025 -11,231.95%
Jun 30, 2025 -1,213.57%
Dec 31, 2024 -147.22%
Sep 30, 2024 -367.01%
Jun 30, 2024 -16,279.79%
Mar 31, 2024 -6,710.47%
Dec 31, 2023 -2,144.80%
Sep 30, 2023 -642.01%
Jun 30, 2023 -813.14%
Mar 31, 2023 -952.61%
Dec 31, 2022 776.38%
Sep 30, 2022 -473.59%
Jun 30, 2022 -220.82%
Mar 31, 2022 -510.10%
Dec 31, 2021 -36.54%
Sep 30, 2021 -324.58%
Jun 30, 2021 -400.37%
Mar 31, 2021 -479.48%
Dec 31, 2020 -348.94%
Sep 30, 2020 -165.55%
Jun 30, 2020 -1,019.60%
Mar 31, 2020 -372.42%
Dec 31, 2019 -78.40%
Sep 30, 2019 -304.44%
Jun 30, 2019 -1,071.18%
Mar 31, 2019 -2,635.90%